Bolt Biotherapeutics (BOLT) Operating Expenses (2020 - 2025)
Historic Operating Expenses for Bolt Biotherapeutics (BOLT) over the last 6 years, with Q3 2025 value amounting to $9.9 million.
- Bolt Biotherapeutics' Operating Expenses fell 4385.81% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.1 million, marking a year-over-year decrease of 4031.19%. This contributed to the annual value of $80.7 million for FY2024, which is 396.56% down from last year.
- Per Bolt Biotherapeutics' latest filing, its Operating Expenses stood at $9.9 million for Q3 2025, which was down 4385.81% from $11.0 million recorded in Q2 2025.
- Bolt Biotherapeutics' Operating Expenses' 5-year high stood at $27.6 million during Q4 2021, with a 5-year trough of $9.9 million in Q3 2025.
- For the 5-year period, Bolt Biotherapeutics' Operating Expenses averaged around $20.6 million, with its median value being $22.1 million (2023).
- As far as peak fluctuations go, Bolt Biotherapeutics' Operating Expenses soared by 11258.84% in 2021, and later plummeted by 5386.23% in 2025.
- Quarter analysis of 5 years shows Bolt Biotherapeutics' Operating Expenses stood at $27.6 million in 2021, then decreased by 18.61% to $22.5 million in 2022, then decreased by 2.65% to $21.9 million in 2023, then decreased by 22.6% to $16.9 million in 2024, then crashed by 41.64% to $9.9 million in 2025.
- Its Operating Expenses was $9.9 million in Q3 2025, compared to $11.0 million in Q2 2025 and $13.3 million in Q1 2025.